Published in Clin Exp Rheumatol on April 07, 2014
Biological treatments in Behçet's disease: beyond anti-TNF therapy. Mediators Inflamm (2014) 1.07
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study. Clin Rheumatol (2015) 0.93
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm (2015) 0.89
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. Front Pharmacol (2016) 0.84
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol (2016) 0.77
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series. Clin Exp Rheumatol (2014) 0.75
Anakinra for resistant Behçet uveitis: why not? Clin Exp Rheumatol (2013) 2.03
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis (2010) 3.47
Colchicine myopathy and neuromyopathy: two cases with different characteristics. J Clin Rheumatol (2010) 2.17
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol (2013) 2.09
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis (2013) 2.09
Mevalonate kinase genotype in children with recurrent fevers and high serum IgD level. Rheumatol Int (2012) 1.95
Intranasal lidocaine and midazolam for procedural sedation in children. Arch Dis Child (2010) 1.61
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis (2012) 1.59
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood (2010) 1.43
The enigma of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Pediatr Infect Dis J (2014) 1.39
Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics (2008) 1.20
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol Int (2010) 1.14
The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: comment on the review by Nigrovic. Arthritis Rheumatol (2014) 1.12
p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells. Blood (2007) 1.09
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. J Pediatr (2010) 1.07
Penile involvement in Henoch-Schönlein purpura with good prognosis. Scand J Urol Nephrol (2007) 1.05
Specific recycling receptors are targeted to the immune synapse by the intraflagellar transport system. J Cell Sci (2014) 1.05
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev (2012) 1.03
The role of infection in Kawasaki syndrome. J Infect (2013) 1.03
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J (2011) 1.03
Debate around infection-dependent hemophagocytic syndrome in paediatrics. BMC Infect Dis (2013) 1.01
Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics (2003) 1.00
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis (2013) 0.98
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol (2012) 0.95
International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) (2014) 0.95
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology (2014) 0.94
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm (2013) 0.93
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol (2014) 0.93
Anakinra treatment in drug-resistant Behcet's disease: a case series. Clin Rheumatol (2013) 0.92
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol (2014) 0.91
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol (2013) 0.91
Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev (2010) 0.90
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol (2012) 0.90
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. Clin Exp Rheumatol (2012) 0.89
Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil (2010) 0.88
Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Ann Intern Med (2012) 0.88
Oral ondansetron versus domperidone for symptomatic treatment of vomiting during acute gastroenteritis in children: multicentre randomized controlled trial. BMC Pediatr (2011) 0.88
Safety issues and concerns of new immunomodulators in rheumatology. Expert Opin Drug Saf (2014) 0.88
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. Blood (2012) 0.88
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol (2014) 0.87
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2014) 0.87
Effects of spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis. Rheumatol Int (2010) 0.87
Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford) (2010) 0.87
Do children's upper respiratory tract infections benefit from probiotics? BMC Infect Dis (2014) 0.86
Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol (2013) 0.86
Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis (2012) 0.86
Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Clin Rheumatol (2014) 0.86
Misdiagnosis of Ewing's sarcoma of the ilium at the pelvis X-ray. Rheumatol Int (2011) 0.86
Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev (2012) 0.86
From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int (2013) 0.85
Sudden shock from capillary leak. Lancet (2012) 0.85
Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol (2010) 0.85
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol (2012) 0.85
Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs (2011) 0.85
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev (2012) 0.84
Autoinflammatory diseases and cardiovascular manifestations. Ann Med (2011) 0.84
Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome. Rheumatol Int (2008) 0.84
Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med (2011) 0.84
Determinants of bone mineral density, bone mineral content, and body composition in a cohort of healthy children: influence of sex, age, puberty, and physical activity. Rheumatol Int (2011) 0.83
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol (2014) 0.83
Kawasaki syndrome and concurrent Coxsackie virus B3 infection. Rheumatol Int (2010) 0.83
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One (2013) 0.83
Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis (2013) 0.83
Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol (2012) 0.83
Interleukin-1 Inhibition in Behçet's disease. Isr Med Assoc J (2016) 0.83